Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 420176011000036113 | bufexamac 50 mg / 1 g cream, 30 g (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 420178011000036112 | bufexamac 5% cream, 30 g | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| bufexamac 5% cream, 30 g | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| bufexamac 5% cream, 30 g | has MPUU | bufexamac 5% cream | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Paraderm 5% cream, 30 g | Is a | True | bufexamac 5% cream, 30 g | Inferred relationship | Some | |
| chlorhexidine gluconate 0.1% + lidocaine hydrochloride 1% + bufexamac 5% cream, 30 g | Is a | True | bufexamac 5% cream, 30 g | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR